Victor Hugo Rodrigues, MD

Articles by Victor Hugo Rodrigues, MD

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer

ByAndre Marcio Murad, MD, PhD,Rodrigo Cunha Guimarães, MD,Bruno Cortes Aragão, MD,Antonio Orlando Scalabrini-neto, MD,Victor Hugo Rodrigues, MD,Renato Garcia

February 1st 2001

In a phase II trial, 29 patients with anthracycline-pretreated or anthracycline-resistant metastatic breast cancer in whom anthracycline-containing first- or second-line chemotherapy failed received combination paclitaxel

Latest Updated Articles

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer
Published: February 1st 2001 | Updated:

Victor Hugo Rodrigues, MD

Articles by Victor Hugo Rodrigues, MD

Gemcitabine and Paclitaxel as Salvage Therapy in Metastatic Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group

What is the Impact of the SHARON Trial on Pancreatic Cancer Research?

Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy

3 Things You Should Know About Single-Agent ADCs in TNBC Treatment

ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma